Connect with us

Health

NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…

Published

on

Article feature image

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
BioEcho receives CE-IVD mark approval for SARS-CoV-2 RNA extraction kit – News-Medical.Net
Article feature image
NSW Jobs Plus program lures medical technology companies to invest in state with promise of tax breaks – The Australian